Trial Profile
A prospective, randomized, single masked, crossover trial comparing intraocular pressure after administration of dorzolamide cyclodextrin microparticle eye drops (DorzNP eye drops) and Trusopt® in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Aug 2016
Price :
$35
*
At a glance
- Drugs Dorzolamide (Primary)
- Indications Glaucoma
- Focus Therapeutic Use
- 31 Aug 2016 New trial record
- 30 Aug 2016 Results presented at 2012 European Association for Vision and Eye Research Conference